• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Luye Pharma Group Ltd.

Headquarters: Shanghai, China
Website: http://www.luye.cn
Year Founded: 1994
Status: Public
Industry Sector: HealthTechnology
CEO: Dian Bo Liu
Number Of Employees: 5,150
Enterprise Value: $1,632,917,242
PE Ratio: 14.41
Exchange/Ticker 1: HKEX:2186
Exchange/Ticker 2: N/A
Latest Market Cap: $945,743,340

BioCentury | Apr 7, 2025
Data Byte

Hong Kong stocks plunge. More tariffs loom

Previously a bright spot in 2025 markets, Hong Kong stocks take a sharp downturn
Read More
BioCentury | Jan 18, 2023
Regulation

Jan. 17 Quick Takes: Moderna now in RSV vaccine regulatory race

Plus: Leap, Flame propose merger and updates from Elicio, Angion, Huadong, CARsgen and more 
Read More
BioCentury | Sep 22, 2021
Management Tracks

CEO Anido out at Aerie after Phase II data

Plus: Sage, Gossamer Bio, Nimbus, Inventiva, Selecta and more
Read More
BioCentury | Feb 4, 2021
Deals

Feb. 3 Quick Takes: Hillhouse takes stakes in InnoCare, Luye; plus Merck KGaA, Inivata, Reverie, Neurocrine, Eisai and more  

InnoCare Pharma Ltd. (HKEX:9969) raised HK$3 billion ($392 million) through the sale of 210.5 million shares at HK$14.45 to Hillhouse, which purchased 191.6 million shares for a 12.77% stake in the
Read More
BioCentury | Jan 23, 2020
Politics & Policy

MNCs lead price cuts in China’s second round of centralized procurement

Read More
BioCentury | Dec 4, 2019
Company News

Dec. 3 Company Quick Takes: Brii adds neuroscience focus; plus Immunomedics, Hanmi-Rapt, Luye-Boan and Cara

Read More
BioCentury | May 1, 2019
Company News

April 30 Company Quick Takes: Merck, G1, Pfizer, Amgen and more

Read More
BioCentury | Mar 29, 2019
Company News

Luye submits NDA for schizophrenia, bipolar disorder therapy

Read More
BioCentury | Feb 7, 2019
Finance

中国创新：威胁还是机遇？

为什么说生物技术产业对中国创新的担忧被夸大了
Read More
BioCentury | Feb 7, 2019
Finance

Chinese Innovation: Threat or Opportunity?

Guest Commentary: Why biotech shows China innovation fears are exaggerated
Read More
Items per page:
1 - 10 of 58